← Back to Bills
HR 9365118th CongressFailed / ExpiredHouse

Pharmacy and Medically Underserved Areas Enhancement Act

Policy Area: Health
View on Congress.gov
Origin Chamber
House
Last Updated
Dec 19, 2024
Latest Action Date
Dec 17, 2024

Latest Action

Referred to the Subcommittee on Health.

Official Summary

Official summary has not been imported yet.

GovScope Watchdog™

AI Government Intelligence™
Executive Summary

The Pharmacy and Medically Underserved Areas Enhancement Act (H.R. 9365) is a health-related bill introduced in the 118th Congress. The bill was referred to the Subcommittee on Health but has since failed or expired. No official summary or full text is available, limiting detailed analysis. The bill likely aimed to address issues related to pharmacy services and access in medically underserved areas, based on its title and policy area classification.

Bottom Line

H.R. 9365 sought to enhance pharmacy services in medically underserved areas but did not advance beyond subcommittee referral and ultimately failed or expired without further legislative action.

Policy Risk Level
🟡 Medium
Neutral Risk Assessment
Key Points
  • The bill was introduced in the House during the 118th Congress and referred to the Subcommittee on Health.
  • It is categorized under the Health policy area, indicating a focus on healthcare access or pharmacy services.
  • No official summary or full text is publicly available, limiting detailed understanding of its provisions.
Who Benefits?

['Residents of medically underserved areas who may gain improved pharmacy access or services', 'Pharmacists and healthcare providers operating in underserved communities', 'Potentially federal health agencies involved in healthcare delivery and oversight']

Potential Concerns

['Lack of publicly available full text and summary restricts assessment of implementation challenges or costs', 'Unclear authority or oversight mechanisms due to missing detailed provisions', 'Potential tradeoffs in resource allocation to pharmacies or underserved areas cannot be evaluated']

Political Context

The bill was introduced and referred to a relevant subcommittee but did not progress further, indicating limited legislative momentum during the 118th Congress. The absence of detailed public documentation suggests it did not receive significant floor consideration or debate.

Hidden Impact Review

Hidden impact flags detected: 2

GovScope reviewed 2 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.

2 Detected
Detected Flags
Indirect Effects

['Potential improvement in healthcare outcomes in underserved areas if provisions were enacted', 'Possible shifts in federal healthcare funding priorities toward pharmacy services', 'Enhanced role for pharmacists in community health management in underserved regions']

GovScope Watchdog Notes

The absence of an official summary and full bill text significantly limits transparency and public understanding of H.R. 9365. This lack of documentation hinders effective oversight and informed debate. Future legislative efforts should ensure full public availability of bill texts and summaries to facilitate accountability.

Passage Likelihood: LowConfidence: 60%Model: gpt-4.1-mini

GovScope Intelligence Roadmap

Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.

Enterprise Ready